After months of intense debate and amendments, Labour's Employment Rights Bill has become law. This marks the most significant change in employment rights in a generation, promising sweeping reforms to strengthen workers' protections across the UK.

The Employment Rights Bill will introduce significant changes impacting employers across all industries. For pharmaceuticals and life sciences organisations, these changes come as workforce expectations evolve and sustainability becomes a marker of good governance. Employers that align legal compliance with fair and transparent employment practices will be best placed to attract and retain skilled talent in a competitive market.

With major reforms to dismissal rights on the horizon, independent schools have only a limited window to review staffing models and implement any planned contractual changes before flexibility is significantly reduced.

The House of Lords has reinserted a number of amendments previously rejected by the Commons, meaning the Employment Rights Bill will return for further consideration.

The Employment Rights Bill has experienced further delays in its parliamentary progression, with the House of Lords again supporting amendments that would directly affect healthcare employers and the wider health and social care workforce.

Peers again backed substantial changes to the Bill in a series of decisive votes, setting up another return to the Commons and raising questions over the timetable for Royal Assent and beyond.